SDC4 is a novel target of the KLF5 transcription factor
Authors:
Open Access
- 24 February 2026
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 809, 153515
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science (25K12026)
This publication has 22 references indexed in Scilit:
- Endothelial HOXB9/SDC4 signaling exacerbates post-ischemic blood-brain and blood-spinal cord barrier disruption by promoting PKCα activationBrain Research Bulletin, 2025
- A stem cell marker KLF5 regulates CCAT1 via three-dimensional genome structure in colorectal cancer cellsBritish Journal of Cancer, 2021
- Diagnostic value of syndecan-4 protein expression in colorectal cancerPathology - Research and Practice, 2021
- Therapeutic potential of targeting membrane-spanning proteoglycan SDC4 in hepatocellular carcinomaCell Death & Disease, 2021
- miR-4711-5p regulates cancer stemness and cell cycle progression via KLF5, MDM2 and TFDP1 in colon cancer cellsBritish Journal of Cancer, 2020
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseasesNature Reviews Drug Discovery, 2017
- TGF-β Tumor Suppression through a Lethal EMTCell, 2016
- Therapeutic targeting of microRNAs: current status and future challengesNature Reviews Drug Discovery, 2014
- Chromatin immunoprecipitation and microarray-based analysis of protein locationNature Protocols, 2006
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006